0001141788 false 0001141788 2023-08-31 2023-08-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): August 31, 2023

 

HEALTH DISCOVERY CORPORATION

(Exact name of registrant as specified in charter)

 

GA   333-62216   74-3002154
(State of incorporation)   (Commission File Number)  

(IRS Employer

Identification No.)

 

2002 SUMMIT BLVD, SUITE 300    
ATLANTA, GA   30319
(Address of principal executive offices)   (Zip Code)

  

(404) 566-4865

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act.

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act.

 

☐ Pre-commencement communications pursuant to Rule 14d–2(b) under the Exchange Act.

 

☐ Pre-commencement communications pursuant to Rule 13e–4(c) under the Exchange Act.

 

Securities registered pursuant to Section 12(g) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, no par value HDVY N/A

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

   

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

William F. Fromholzer, at the age of 77, will retire from the board of directors of Health Discovery Corporation (the “Company”) by October 1, 2023. Mr. Fromholzer issued the following statement: “My tenure as a director was one of the great experiences of my career and I look forward to watching the Company continue to move forward with SVM-RFE in the world of AI and in the development of identifying early stage diagnostics for common health issues.”

 

Item 7.01 Regulation FD Disclosure.

 

On August 31, 2023, Health Discovery Corporation (the “Company”) agreed to the terms of a settlement agreement for the patent infringement claims asserted against Intel Corporation in Health Discovery Corporation v. Intel Corporation, Case Nos. 6:20-cv-00666-ADA (W.D. Tex.), 6:20-cv-00356-ADA (W.D. Tex.). The agreement provides for the payment of $2,250,000 by Intel Corporation to the Company and release and dismissal of all claims against Intel Corporation with prejudice. A stipulation of dismissal was filed on September 15, 2023, and all asserted claims were dismissed with prejudice on September 18, 2023.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 2 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

  HEALTH DISCOVERY CORPORATION
  Registrant

 

 

  
Dated:  October 17, 2023 By: /s/ Colleen Hutchinson
   

Colleen Hutchinson

Board Member

 

 

 

 

 

 

 

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 3 

 

v3.23.3
Cover
Aug. 31, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Aug. 31, 2023
Entity File Number 333-62216
Entity Registrant Name HEALTH DISCOVERY CORPORATION
Entity Central Index Key 0001141788
Entity Tax Identification Number 74-3002154
Entity Incorporation, State or Country Code GA
Entity Address, Address Line One 2002 SUMMIT BLVD
Entity Address, Address Line Two SUITE 300
Entity Address, City or Town ATLANTA
Entity Address, State or Province GA
Entity Address, Postal Zip Code 30319
City Area Code (404)
Local Phone Number 566-4865
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Trading Symbol HDVY
Title of 12(g) Security Common Stock, no par value
Entity Emerging Growth Company false
Health Discovery (CE) (USOTC:HDVY)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024 Haga Click aquí para más Gráficas Health Discovery (CE).
Health Discovery (CE) (USOTC:HDVY)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024 Haga Click aquí para más Gráficas Health Discovery (CE).